Compare PMVP & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PMVP | ZENV |
|---|---|---|
| Founded | 2013 | 2005 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.8M | 16.5M |
| IPO Year | 2020 | 2021 |
| Metric | PMVP | ZENV |
|---|---|---|
| Price | $1.56 | $0.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 815.0K | 610.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.75 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.82 | $0.25 |
| 52 Week High | $1.88 | $2.16 |
| Indicator | PMVP | ZENV |
|---|---|---|
| Relative Strength Index (RSI) | 60.27 | 47.96 |
| Support Level | $1.32 | $0.25 |
| Resistance Level | $1.56 | $1.00 |
| Average True Range (ATR) | 0.14 | 0.07 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 60.71 | 58.32 |
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
Zenvia Inc provides a platform that enables companies to create journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.